WO2006016020A3 - Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan - Google Patents
Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan Download PDFInfo
- Publication number
- WO2006016020A3 WO2006016020A3 PCT/FR2005/001398 FR2005001398W WO2006016020A3 WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3 FR 2005001398 W FR2005001398 W FR 2005001398W WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymer
- nanoparticles
- active principle
- bisulfan
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0407569 | 2004-07-07 | ||
FR0407569A FR2872703B1 (fr) | 2004-07-07 | 2004-07-07 | Nanoparticules polymeriques composites |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006016020A2 WO2006016020A2 (fr) | 2006-02-16 |
WO2006016020A3 true WO2006016020A3 (fr) | 2006-07-13 |
Family
ID=34946547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2005/001398 WO2006016020A2 (fr) | 2004-07-07 | 2005-06-07 | Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2872703B1 (fr) |
WO (1) | WO2006016020A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010523557A (ja) * | 2007-03-30 | 2010-07-15 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 疎水性量子ドットのカプセル化 |
HUE034480T2 (en) | 2011-04-28 | 2018-02-28 | Platform Brightworks Two Ltd | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for their preparation and use |
CA2913328C (fr) | 2013-05-28 | 2021-08-24 | Sintef Tto As | Procede de preparation de nanoparticules furtives |
CN108453927A (zh) * | 2018-02-08 | 2018-08-28 | 西安交通大学 | 一种可生物降解PCL/Mg复合材料FDM耗材的制备工艺 |
JP7317038B2 (ja) * | 2018-03-27 | 2023-07-28 | シンテフ ティーティーオー エイエス | がん治療に使用するためのポリ(アルキルシアノアクリレート)ナノ粒子 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007895A1 (fr) * | 1978-07-19 | 1980-02-06 | Patrick Couvreur | Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation |
FR2608942A1 (fr) * | 1986-12-31 | 1988-07-01 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
EP0447318A1 (fr) * | 1990-03-16 | 1991-09-18 | L'oreal | Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant |
WO1996031231A1 (fr) * | 1995-04-04 | 1996-10-10 | Elan Corporation, Plc | Nanoparticules biodegradables a liberation lente renfermant de l'insuline |
WO1999043359A1 (fr) * | 1998-02-27 | 1999-09-02 | Bioalliance Pharma (S.A.) | Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines |
WO2003017987A1 (fr) * | 2001-08-31 | 2003-03-06 | Mcgill University | Nanocapsules polymeres biodegradables et utilisation de celles-ci |
CN1417242A (zh) * | 2002-11-14 | 2003-05-14 | 天津大学 | 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法 |
-
2004
- 2004-07-07 FR FR0407569A patent/FR2872703B1/fr not_active Expired - Fee Related
-
2005
- 2005-06-07 WO PCT/FR2005/001398 patent/WO2006016020A2/fr not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0007895A1 (fr) * | 1978-07-19 | 1980-02-06 | Patrick Couvreur | Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation |
FR2608942A1 (fr) * | 1986-12-31 | 1988-07-01 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
EP0447318A1 (fr) * | 1990-03-16 | 1991-09-18 | L'oreal | Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant |
WO1996031231A1 (fr) * | 1995-04-04 | 1996-10-10 | Elan Corporation, Plc | Nanoparticules biodegradables a liberation lente renfermant de l'insuline |
WO1999043359A1 (fr) * | 1998-02-27 | 1999-09-02 | Bioalliance Pharma (S.A.) | Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines |
WO2003017987A1 (fr) * | 2001-08-31 | 2003-03-06 | Mcgill University | Nanocapsules polymeres biodegradables et utilisation de celles-ci |
CN1417242A (zh) * | 2002-11-14 | 2003-05-14 | 天津大学 | 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 200370, Derwent World Patents Index; Class A14, AN 2003-732339, XP002317291 * |
HASSAN M ET AL: "A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem transplantation: 500 mg/m<2> as a optimal total dose for conditioning", BONE MARROW TRANSPLANTATION 2002 UNITED KINGDOM, vol. 30, no. 12, 2002, pages 833 - 841, XP002367646, ISSN: 0268-3369 * |
Also Published As
Publication number | Publication date |
---|---|
FR2872703B1 (fr) | 2006-10-06 |
WO2006016020A2 (fr) | 2006-02-16 |
FR2872703A1 (fr) | 2006-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2368581A3 (fr) | Particules d'embolisation intravasculaire poreuses et procédés apparentés | |
WO2009001697A3 (fr) | Microsphères ayant une structure noyau/enveloppe | |
WO2008014464A3 (fr) | Nanoparticules de polymères de type noyau-enveloppe avec une région d'interphase | |
TWI367230B (en) | Surface-modified nanoparticles, their preparation and use | |
WO2011084521A3 (fr) | Nanoparticules polymères thérapeutiques comportant de l'épothilone et leurs procédés de fabrication et d'utilisation | |
WO2010077628A3 (fr) | Composition d'hygiène personnelle sous la forme d'un article à structure solide soluble et poreuse | |
WO2005076938A3 (fr) | Nano-agregats magnetiques recouverts de plusieurs polymeres | |
WO2005118128A8 (fr) | Embolisation | |
EP1719554A3 (fr) | Matériaux aromatiques encapsulés et procédés pour leur préparation | |
EP2305787A3 (fr) | Compositions comprenant des particules de délivrance contenant un agent bénéfique | |
EP1935483A3 (fr) | Matériaux actif encapsulé contenant un matériaux à échelle nanométrique | |
EP2045214A3 (fr) | Nanotube de nanoparticule-halloysite d'or et son procédé de formation | |
EP1640811A3 (fr) | Révélateur | |
WO2006016020A3 (fr) | Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan | |
WO2005094156A3 (fr) | Oxydes metalliques a modification de surface, procedes de production desdits oxydes metalliques et leur utilisation dans des preparations cosmetiques | |
EP1874443A4 (fr) | Membranes nanoporeuses ultrafines, procede de fabrication et leurs utilisations | |
WO2007076990A3 (fr) | Particules d'agglomerat, procede de production de nanocomposites et leur utilisation | |
WO2008007290A3 (fr) | nanoparticules à noyau/enveloppe à des fins de thérapie et d'imagerie | |
AU2002330851A1 (en) | Functionalized fullerenes, their method of manufacture and uses thereof | |
WO2008070555A3 (fr) | Microparticules de mousse d'amidon | |
WO2005089297A3 (fr) | Coussin a geometrie variable a auto ventilation et a auto refroidissement | |
WO2007120193A3 (fr) | Nanobiomatieres et leur synthese | |
ZA200607987B (en) | Stable aqueous particle dispersion the use thereof and method for producing said dispersion | |
WO2007030254A3 (fr) | Procedes de production de nanoparticules a base de tungstene | |
WO2006071746A3 (fr) | Neurones de dopamine modifies et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |